Redeye provides an update on Physitrack ahead of its Q2’23-results (scheduled for 15 August), anticipating a steady quarter marked by favourable margin improvements. We have slightly adjusted our estimates, considering the emphasis on attracting higher-margin customers indicating less intense topline figures but enhancing operational efficiency.